FDA Inspection 1255239 — St. Luke's Cancer Institute

St. Luke's Cancer Institute — FEI 3004380123

The FDA completed an inspection of St. Luke's Cancer Institute on November 18, 2024 in Twin Falls, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 18, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Twin Falls, ID (United States)